Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective

Full text
Author(s):
Ulrich, Henning [1] ; Pillat, Micheli M. [2] ; Tarnok, Attila [3, 4, 5]
Total Authors: 3
Affiliation:
[1] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo - Brazil
[2] Univ Fed Santa Maria, Dept Microbiol & Parasitol, Hlth Sci Ctr, Santa Maria, RS - Brazil
[3] Univ Leipzig, Inst Med Informat Stat & Epidemiol IMISE, Leipzig - Germany
[4] Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Therapy Validat, Perlickstr 1, D-04103 Leipzig - Germany
[5] Tsinghua Univ, Dept Precis Instrument, Beijing - Peoples R China
Total Affiliations: 5
Document type: Review article
Source: Cytometry Part A; v. 97, n. 7, SI JUN 2020.
Web of Science Citations: 1
Abstract

SARS-CoV-2 pandemic and recurrent dengue epidemics in tropical countries have turned into a global health threat. While both virus-caused infections may only reveal light symptoms, they can also cause severe diseases. Here, we review the possible antibody-dependent enhancement (ADE) occurrence, known for dengue infections, when there is a second infection with a different virus strain. Consequently, preexisting antibodies do not neutralize infection, but enhance it, possibly by triggering Fc gamma receptor-mediated virus uptake. No clinical data exist indicating such mechanism for SARS-CoV-2, but previous coronavirus infections or infection of SARS-CoV-2 convalescent with different SARS-CoV-2 strains could promote ADE, as experimentally shown for antibodies against the MERS-CoV or SARS-CoV spike S protein. (c) 2020 International Society for Advancement of Cytometry (AU)

FAPESP's process: 18/08426-0 - Indole alkaloid sub products of Maqui (Aristotelia chilensis) processing as food additives to Alzheimer's Disease treatment
Grantee:Alexander Henning Ulrich
Support Opportunities: Regular Research Grants